X Marks the Spot: Sex Differences in Clinical Presentation and Therapeutic Outcomes in XLH

The molecular mechanisms behind sex differences in some bone diseases and disorders of calcium and phosphate metabolism are sometimes not obvious, and may be related to hormones, genetic factors, or both. Sexually dimorphic diseases including male osteoporosis, primary hyperparathyroidism, and X-linked hypophosphataemia will be discussed in this symposium, focusing on specificities in their pathogenesis and treatment outcomes.

Is Osteoporosis Different in Men and Women?

Eric S Orwoll, MD

Oregon Health & Sciences University

She Said, He Said: Sex Differences in Hyperparathyroidism Presentations and Outcomes

Neil John Gittoes, MD, PhD

Centre for Endocrinology, Diabetes and Metabolism

X Marks the Spot: Sex Differences in Clinical Presentation and Therapeutic Outcomes in XLH

Agnes Linglart, MD, PhD

PARIS SACLAY UNIVERSITY

Chair

Gina Woods, MD

University of California, San Diego

Chair

Jad G Sfeir, MD, MS

Mayo Clinic